A Robot (My Special Aflac Duck) for the Reduction of Medical Setting Distress in Pediatric Cancer Patients

Active:	Yes
Cancer Type:	Hematopoietic Malignancies Solid Tumor	NCT ID:	NCT04409301
Trial Phases:		Protocol IDs:	AFLAC4875-19 (primary) NCI-2019-08591
Eligibility:	3 - 10 Years, Male and Female	Study Type:	Supportive care
Study Sponsor:	Children's Healthcare of Atlanta - Egleston
NCI Full Details:	http://clinicaltrials.gov/show/NCT04409301

Summary

This trial studies how well a robot called My Special Aflac Duck (MSAD) works in reducing medical setting distress in pediatric cancer patients. MSAD is an animatronic device that provides elements of distraction to children undergoing stressful and painful medical procedures. Providing pediatric cancer patients with MSAD may distract them and minimize distress over the early course of their treatment.

Objectives

PRIMARY OBJECTIVES:
I. To determine how MSAD impacts reported medical setting distress over time for pediatric oncology patients.
II. To examine changes in the utilization of MSAD over time.
III. To determine if there are differences in utilization of MSAD by age, race, ethnicity, or cancer diagnosis, and whether these differences affect distress outcomes.

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I (MSAD HOSPITALS): Patients use the MSAD robot for 3 months.

ARM II (CONTROL HOSPITALS): Patients receive standard of care for 3 months, and may then use the MSAD robot at the end of the study.

Treatment Sites in Georgia

Aflac Cancer and Blood Disorders Center of Children’s at Egleston
1405 Clifton Road NE
3rd Floor
Atlanta, GA 30322
404-785-0853
www.choa.org

Winship Cancer Institute of Emory University
1365 Clifton Road NE
Building C
Atlanta, GA 30322
winshipcancer.emory.edu

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.